€ 45.66
Key Takeaways
Risk factor
Good trading liquidity
Profitability factor
Weak growth
About
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Target Price
The average target price of AFX.DE is 51 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
